Sign Up
Stories
Growing Markets in Nutrition and Obesity
Share
GLP-1 Agonists: Impact and Rebound
Growing Healthcare Markets in South Afri...
Anti-Obesity Meds' Impact on Allurion Pr...
Antithrombotic/Anticoagulant Drugs Marke...
AscellaHealth Forecasts Robust Outlook f...
Overview
API
The global market for fat replacers is projected to reach $5.5 billion by 2030, driven by the increasing prevalence of obesity and chronic diseases worldwide. The anti-obesity drugs market is expected to grow at a CAGR of over 23% from 2023 to 2030, reaching $14.8 billion. The global obesity market is expected to expand at a CAGR of 14.4% during the forecast period of 2024-2029, reaching $61.7 billion by the end of 2029. The North America weight management products market is projected to reach $9.64 billion by 2028.
Ask a question
How are advancements in technology impacting the development of fat replacers and anti-obesity drugs?
How can policymakers and healthcare providers effectively address the rising prevalence of obesity and chronic diseases?
What are the potential challenges and opportunities for companies operating in these growing markets?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Apr 2023
May 2023
Jun 2023
Jul 2023
Aug 2023
Coverage